2-70943684-G-A
Variant summary
Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PM2PP3_Strong
The ENST00000234396.10(ATP6V1B1):c.145G>A(p.Gly49Arg) variant causes a missense change. The variant allele was found at a frequency of 0.000013 in 1,613,698 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Synonymous variant affecting the same amino acid position (i.e. G49G) has been classified as Likely benign.
Frequency
Consequence
ENST00000234396.10 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ATP6V1B1 | NM_001692.4 | c.145G>A | p.Gly49Arg | missense_variant | 2/14 | ENST00000234396.10 | NP_001683.2 | |
ATP6V1B1-AS1 | NR_110274.1 | n.386-1251C>T | intron_variant, non_coding_transcript_variant | |||||
ATP6V1B1-AS1 | NR_110273.1 | n.524-1251C>T | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ATP6V1B1 | ENST00000234396.10 | c.145G>A | p.Gly49Arg | missense_variant | 2/14 | 1 | NM_001692.4 | ENSP00000234396 | P1 | |
ATP6V1B1-AS1 | ENST00000422761.1 | n.523-1251C>T | intron_variant, non_coding_transcript_variant | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000592 AC: 9AN: 152082Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000159 AC: 4AN: 250856Hom.: 0 AF XY: 0.0000148 AC XY: 2AN XY: 135584
GnomAD4 exome AF: 0.00000821 AC: 12AN: 1461616Hom.: 0 Cov.: 33 AF XY: 0.00000963 AC XY: 7AN XY: 727108
GnomAD4 genome AF: 0.0000592 AC: 9AN: 152082Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74284
ClinVar
Submissions by phenotype
not provided Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Jun 20, 2024 | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge - |
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Mar 01, 2022 | This sequence change replaces glycine, which is neutral and non-polar, with arginine, which is basic and polar, at codon 49 of the ATP6V1B1 protein (p.Gly49Arg). This variant is present in population databases (rs369442690, gnomAD 0.03%). This variant has not been reported in the literature in individuals affected with ATP6V1B1-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C15"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
ATP6V1B1-related disorder Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jun 07, 2024 | The ATP6V1B1 c.145G>A variant is predicted to result in the amino acid substitution p.Gly49Arg. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.020% of alleles in individuals of African descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at